Chronic Idiopathic Constipation Market is expected to grow at a CAGR of 7.4% during the forecast period PREPARED BY Market Research Future (Part of Wantstats Research & Media Pvt. Ltd.) SAMPLE FOR MORE INFO

Market Highlights The market in Asia Pacific is expected to grow rapidly in the coming years. By studying and analyzing the market, it shows that this region has a good growth potential due to increasing unhealthy eating habits and unhygienic conditions. The other major chronic disease found in this region is the gastric cancer. Segmentation The global chronic idiopathic constipation market is segmented on the basis of diagnosis, treatment, and end-user. On the basis of diagnosis, the market is segmented into blood tests, sigmoidoscopy, colonoscopy, balloon expulsion tests, anorectal manometry, colonic transit study, defecography, and others. On the basis of treatment, the market is segmented into drug and surgery. Drugs are further segmented into acid neutralizers, laxatives and antidiarrheal, antiemetics, antiulcer, lubiprostone (amitiza) and linaclotide (linzess), misoprostol (Cytotec), colchicine/probenecid (Col-Probenecid) and Onabotulinumtoxin A (also called botulinum toxin type A or Botox), and others. On the basis of end-user, the market is segmented into hospitals, gastroenterology clinics, diagnostic centers, and others. Request For Sample Report: Chronic Idiopathic Constipation Market

Chronic Idiopathic Constipation Market Regional Analysis The Americas dominates the global chronic idiopathic constipation market owing to the increasing prevalence of chronic constipation and the presence of a well-developed healthcare sector within the region. Moreover, the increasing healthcare expenditure and the presence of key players within regional boundaries provide a favorable background for the market growth. Europe is the second largest in the global chronic idiopathic constipation market. Factors such as the increasing availability of funds for research and a huge patient population followed by a well-developed healthcare sector drive the market within the region. Asia Pacific is estimated to be the fastest growing market for chronic idiopathic constipation. This can be attributed to the presence of developing economies such as India and China and a huge patient population. Moreover, the increasing healthcare expenditure and a rapidly developing healthcare sector boost the market growth within the region.

Chronic Idiopathic Constipation Market Key Players Some of the key players in this market are Actavis (U.S.), Chugai Pharmaceutical (Japan), Ferring International Center S.A.(Switzerland), Synergy Pharmaceuticals (U.S.), Pfizer Inc (U.S.), GlaxoSmithKline (U.K.), Sanofi (France), Bayer (Germany), Salix Pharmaceuticals Ltd (U.S.), Sucampo Pharmaceuticals Inc (U.S.), Ironwood Pharmaceuticals (U.S.), Progenics Pharmaceuticals (U.S.), F. Hoffmann-La Roche AG (Switzerland), Boehringer Ingelheim GmbH (Germany), Daewoong Co. Ltd.(South Korea), Synergy Pharmaceuticals, Inc. (U.S.), and others. Ask for discount:

ABOUT US MARKET RESEARCH FUTURE At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. For more information kindly visit or contact us at Copyright © 2018 Market Research Future All Rights Reserved. This document contains highly confidential information and is the sole property of Market Research Future. No part of it may be circulated, copied, quoted, or otherwise reproduced without the written approval of Market Research Future.

MARKET RESEARCH FUTURE THANK YOU Ph: (US) Ph: (UK)